Study of XB010 in Subjects With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
- Status
- RECRUITING
- Phase
- PHASE3
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
ETC-159 In Combination With Pembrolizumab In Advanced MSS/pMMR Ovarian Cancers
- Status
- RECRUITING
- Phase
- PHASE1
First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
- Status
- RECRUITING
- Phase
- PHASE2